Quantcast

Latest Drug Development Stories

2014-09-30 23:22:37

In a recent online interview by the Pharma IQ Division of the International Quality & Productivity Center (IQPC), James L. Sherley, M.D., Ph.D., the Director of the Adult Stem Cell Technology Center, LLC (ASCTC) discussed the state of technology for drug evaluations for stem cell toxicity. As an expert on the topic, Dr. Sherley emphasized that, currently, few technologies exist for screening-out drug candidates that will ultimately fail as medicines due to toxicity against stem cells...

2014-09-26 08:25:19

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental...

2014-09-25 23:10:50

A year after its formation in September 2013, Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) was invited to present its commercialization plans and progress at the 7th Annual BioPharm America™ International Partnering Conference held in Boston from September 22-24. Over the three-day conference, the ASCTC presented to pharmaceutical executives and pharmaceutical investors its one-of-a-kind technologies poised to revolutionize stem cell medicine. Boston, Massachusetts (PRWEB)...

2014-09-25 12:30:11

DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process. 'Outsourcing in Drug Discovery' provides an in depth look into the...

2014-09-19 23:08:36

SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detection of benzodiazepine-evoked pharmacodynamic CNS effects. Baltimore, MD (PRWEB) September 19, 2014 SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit...

2014-09-19 08:25:37

--Use of Crowdsourced Clinical Trial Protocols and Telemonitoring for Remote Patient Data Collection Is Potential Game-Changer for Orphan Diseases NEW YORK, Sept. 19, 2014 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it is applying its expertise in crowdsourcing and digital telemonitoring technology to conduct a clinical trial of Auven Therapeutics' Kiacta(TM)( )in...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-16 23:15:45

Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in Scottsdale, would like to jointly announce CRAB’s assumption of responsibility for the PCRT, a world-renowned consortium comprised of a team of pancreatic cancer experts committed to improve treatment outcomes for patients with this deadly cancer. Seattle, WA (PRWEB) September 16, 2014 Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in...

2014-09-16 23:03:11

Topical research report “Pediatric Drug Development - Regulatory Challenges and Commercial Opportunities” worked out by CBR Pharma Insights is now available at MarketPublishers.com. London, UK (PRWEB) September 16, 2014 Since the adoption of pediatric legislation, the number of paediatric clinical trials has risen considerably in line with increased investment in R&D for pediatric drugs. In the USA, over 350 product labels include novel paediatric information and more than 130...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related